Sfoglia per Autore
Conjugation of gold nanoparticles with multidentate surfactants for enhanced stability and biological properties
2023 Rotem, R; Giustra, M; Arrigoni, F; Bertolini, J; Garbujo, S; Rizzuto, M; Salvioni, L; Barbieri, L; Bertini, L; De Gioia, L; Colombo, M; Prosperi, D
Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2
2023 Rotem, R; Bertolini, J; Salvioni, L; Barbieri, L; Rizzuto, M; Tinelli, V; Gori, A; Adams, S; Colombo, M; Prosperi, D
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells
2022 Colombo, M; Marongiu, L; Mingozzi, F; Marzi, R; Cigni, C; Facchini, F; Rotem, R; Valache, M; Stucchi, G; Rocca, G; Gornati, L; Rizzuto, M; Salvioni, L; Zanoni, I; Gori, A; Prosperi, D; Granucci, F
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies
2021 Rizzuto, M; Dal Magro, R; Barbieri, L; Pandolfi, L; Sguazzini-Viscontini, A; Truffi, M; Salvioni, L; Corsi, F; Colombo, M; Re, F; Prosperi, D
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages
2021 Rensi, N; Sammarco, A; Moccia, V; Calore, A; Torrigiani, F; Prosperi, D; Rizzuto, M; Bellini, M; De Maria, R; Bonsembiante, F; Ferro, S; Zanetti, R; Zappulli, V; Cavicchioli, L
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax
2021 Sitia, L; Bonizzi, A; Mazzucchelli, S; Negri, S; Sottani, C; Grignani, E; Rizzuto, M; Prosperi, D; Sorrentino, L; Morasso, C; Allevi, R; Sevieri, M; Silva, F; Truffi, M; Corsi, F
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems
2020 Rotem, R; Micale, A; Rizzuto, M; Migliavacca, M; Giustra, M; Salvioni, L; Tasin, F; Prosperi, D; Colombo, M
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer
2020 Bellini, M; Riva, B; Tinelli, V; Rizzuto, M; Salvioni, L; Colombo, M; Mingozzi, F; Visioli, A; Marongiu, L; Frascotti, G; Christodoulou, M; Passarella, D; Prosperi, D; Fiandra, L
Exploiting Nanotechnology to Improve Cancer Immunotherapy and Overcome Biological Barriers
2019 Rizzuto, M
Are nanotechnological approaches the future of treating inflammatory diseases?
2019 Rizzuto, M; Salvioni, L; Rotem, R; Colombo, M; Zanoni, I; Granucci, F; Prosperi, D
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer
2019 Bonizzi, A; Colombo, M; Rizzuto, M; Pacini, C; Pandolfi, L; Truffi, M; Monieri, M; Catrambone, F; Fiandra, L; Corsi, F; Prosperi, D; Mazzucchelli, S
Thirty years of cancer nanomedicine: Success, frustration, and hope
2019 Salvioni, L; Rizzuto, M; Bertolini, J; Pandolfi, L; Colombo, M; Prosperi, D
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells
2019 Avvakumova, S; Pandolfi, L; Soprano, E; Moretto, L; Bellini, M; Galbiati, E; Rizzuto, M; Colombo, M; Allevi, R; Corsi, F; Sanchez Iglesias, A; Prosperi, D
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity
2018 Riva, B; Bellini, M; Corvi, E; Verderio, P; Rozek, E; Colzani, B; Avvakumova, S; Radeghieri, A; Rizzuto, M; Morasso, C; Colombo, M; Prosperi, D
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer
2018 Colombo, M; Rizzuto, M; Pacini, C; Pandolfi, L; Bonizzi, A; Truffi, M; Monieri, M; Catrambone, F; Giustra, M; Garbujo, S; Fiandra, L; Corsi, F; Prosperi, D; Mazzucchelli, S
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer
2017 Mazzucchelli, S; Truffi, M; Bellini, M; Rizzuto, M; Prosperi, D; Corsi, F
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells
2017 Pandolfi, L; Bellini, M; Vanna, R; Morasso, C; Zago, A; Carcano, S; Avvakumova, S; Bertolini, J; Rizzuto, M; Colombo, M; Prosperi, D
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity
2017 Mazzucchelli, S; Bellini, M; Fiandra, L; Truffi, M; Rizzuto, M; Sorrentino, L; Longhi, E; Nebuloni, M; Prosperi, D; Corsi, F
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer
2017 Mazzucchelli, S; Truffi, M; Baccarini, F; Beretta, M; Sorrentino, L; Bellini, M; Rizzuto, M; Ottria, R; Ravelli, A; Ciuffreda, P; Prosperi, D; Corsi, F
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells
2014 Bellini, M; Mazzucchelli, S; Galbiati, E; Sommaruga, S; Fiandra, L; Truffi, M; Rizzuto, M; Colombo, M; Tortora, P; Corsi, F; Prosperi, D
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile